Institute for Translational Drug Development

The Institute for Translational Drug Development (ITDD) is a specialized contract research organization (CRO) and consultancy based in Toulouse, France, focused on early-phase oncology drug development. Founded by leading oncologists, the company provides strategic guidance, regulatory support, and clinical trial management for biotechnology and pharmaceutical companies transitioning from preclinical to clinical stages. ITDD excels in designing and executing Phase 1 and Phase 2 trials, leveraging a deep network of clinical investigators and expertise in innovative trial designs. Their services encompass medical writing, safety monitoring, and translational research integration to accelerate the delivery of novel cancer therapies. The organization plays a pivotal role in the European oncology ecosystem by bridging the gap between laboratory discovery and clinical proof-of-concept.